Rating Action: Moody's rates CVS' proposed senior unsecured notes Baa2. Global Credit Research- 09 Aug 2021. New York, August 09, 2021-- Moody's Investors Service, today assigned a Baa2 rating to CVS Health Corporation's proposed new senior unsecured notes offering.
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
The general evaluation of AETNA INCO. (US), a company active in the Health Care Providers industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date November 30, 2018, the closing price was USD 212.70 ...
Aetna’s merger with CVS will transform the healthcare space as we know it, as the combined entity will seek to implement a new business model predicated upon the direct management of member medical care. As we have previously stated, we are largely positive regarding the deal and believe the new healthcare conglomerate will be able to leverage several key pieces of the healthcare ecosystem into better medical cost management. Additionally, we believe Aetna shareholders are gaining a great deal...
Aetna’s merger with CVS will transform the healthcare space as we know it, as the combined entity will seek to implement a new business model predicated upon the direct management of member medical care. As we have previously stated, we are largely positive regarding the deal and believe the new healthcare conglomerate will be able to leverage several key pieces of the healthcare ecosystem into better medical cost management. Additionally, we believe Aetna shareholders are gaining a great deal...
There was a lot to digest from CVS' second quarter, but we believe the positive quarterly results, the firm’s rigorous defense of its pharmacy benefit manager business, and encouraging update related to its proposed Aetna acquisition reinforce our positive outlook for the healthcare services conglomerate. We are reiterating our $96 fair value estimate, which incorporates the Aetna acquisition, and narrow moat rating for the combined entity. Considering the significant discount CVS’ equity cu...
There was a lot to digest from CVS' second quarter, but we believe the positive quarterly results, the firm’s rigorous defense of its pharmacy benefit manager business, and encouraging update related to its proposed Aetna acquisition reinforce our positive outlook for the healthcare services conglomerate. We are reiterating our $96 fair value estimate, which incorporates the Aetna acquisition, and narrow moat rating for the combined entity. Considering the significant discount CVS’ equity cu...
There was a lot to digest from CVS' second quarter, but we believe the positive quarterly results, the firm’s rigorous defense of its pharmacy benefit manager business, and encouraging update related to its proposed Aetna acquisition reinforce our positive outlook for the healthcare services conglomerate. We are reiterating our $96 fair value estimate, which incorporates the Aetna acquisition, and narrow moat rating for the combined entity. Considering the significant discount CVS’ equity cu...
Aetna reported a mixed quarter with operating revenue remaining flat and operating margin decreasing 37 basis points to 10.07%. The firm did a great job in controlling its medical costs as the overall medical cost ratio decreased 30 basis points to 79.7% and was driven largely from a 140-basis-point medical loss ratio decrease (to 77.1%) for the commercial segment. However, the firm's government segment, which largely includes Medicare membership, increased 50 basis points to 81.8%. We believe t...
Aetna reported a mixed quarter with operating revenue remaining flat and operating margin decreasing 37 basis points to 10.07%. The firm did a great job in controlling its medical costs as the overall medical cost ratio decreased 30 basis points to 79.7% and was driven largely from a 140-basis-point medical loss ratio decrease (to 77.1%) for the commercial segment. However, the firm's government segment, which largely includes Medicare membership, increased 50 basis points to 81.8%. We believe t...
On June 28, Amazon announced it will purchase mail-order pharmacy startup PillPack. This move will give Amazon a foothold within the pharmaceutical supply chain and was the most logical step for the online conglomerate to make as we believed retail pharmacy was going to be the easiest segment of the pharmaceutical supply chain for Amazon to enter. However, we also believe it will still be tough for the firm to create any major disruption within the healthcare space given the insurance dynamics t...
HARTFORD, Conn.--(BUSINESS WIRE)-- Aetna (NYSE: AET) will hold its Annual Meeting of Shareholders on Friday, May 18, 2018, at 9:30 a.m. ET in New York City. The meeting will be accessible through a live, audio-only webcast on the company’s Investor Information website, www.aetna.com/investor. A webcast replay will be available after the event. Anyone attending or listening to the meeting is encouraged to read the company’s 2017 Annual Report on Form 10-K and its Quarterly Report on Form 10-Q for the first quarter of 2018, inc...
We are reiterating our $181 fair value estimate and narrow moat rating for Aetna after it reported decent quarterly results. While there were no major surprises reported by the MCO, it did execute on reorganizing its operations in order to prepare for its merger with CVS. Aetna has reorganized its operations by combining all healthcare related activities under one segment and has divested its other nonhealthcare insurance businesses. The firm also acquired 279,000 new Medicare members as it look...
HARTFORD, Conn.--(BUSINESS WIRE)-- Aetna (NYSE: AET) announced first-quarter 2018 net income(1) of $1.2 billion, or $3.67 per share. Adjusted earnings(2) for first-quarter 2018 were $1.1 billion, or $3.19 per share. “Our core businesses performed well in the quarter, generating strong earnings per share growth and delivering significant value to our members, clients and shareholders,” said Mark T. Bertolini, Aetna chairman and CEO. “Our Medicare growth strategy remains on track as we grew to serve nearly 250,000 additional Me...
HARTFORD, Conn.--(BUSINESS WIRE)-- Aetna (NYSE: AET) today announced that first-quarter 2018 results will be made public on Tuesday, May 1, at 6:30 a.m. ET. Given the pending transaction with CVS Health, Aetna will not host a conference call in conjunction with its earnings release and does not expect to do so for future quarters. Effective for the first quarter of 2018, Aetna realigned its business segments to correspond with changes to its management structure and internal management reporting, which reflect the company's e...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.